| Drug Discovery and Production - How to make your laboratory more efficient, versatile and sustainable |
|
|
|
|
| |
|
| |
The latest drug discovery news from News Medical |
|
|
|
 | | |
 Utilizing Custom Solutions for Robotics & Automation
This short article highlights a specific case study with the French pharmaceutical company Sanofi, which partnered with NuAire to develop custom Class II Biosafety Cabinets to accommodate the increasing need for automation and oversized equipment in their labs.
| |
|
|
| | | | |  Janus kinase inhibitors (JAKi) and biologics are the cornerstone of modern treatment for rheumatoid arthritis (RA). But there have been concerns over long-term side effects. | | | | |  Insilico Medicine, a clinical stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it combined two rapidly developing technologies, quantum computing and generative AI, to explore lead candidate discovery in drug development and successfully demonstrated the potential advantages of quantum generative adversarial networks in generative chemistry. | | | | |  Researchers at the University of Warwick and The James Cook University Hospital, Middlesbrough have led a clinical trial, funded by the National Institute for Health and Care Research (NIHR), on a new treatment which can help people stop needing to use opioid painkillers to manage chronic pain. | | | | |  Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago. | | | | |  At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more. | | | | |  The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations. | | | | |  Automation can greatly enhance the drug discovery screening process, mostly by speeding it up and reducing the resources needed to be dedicated to it. | |
|
|
|
|
|
|
|
